# M4 Organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use Guidance for Industry - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/m4-organization-of-the-common-technical-document-for-the-registration-of-pharmaceuticals-for-human-use-guidance-for-industry/e5a79d19-73aa-4d4c-baa8-342b5ddc7632

> FDA guidance document: M4 Organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use Guidance for Industry. Issue date: October 03, 2017. Get complete insights and analysis.

---

## Details

- Title: M4 Organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-10-03
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-5139">FDA-2017-D-5139</a>

## Related Documents

- [Prescription Drug User Fee Act Waivers, Reductions, and Refunds for Drug and Biological Products Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/prescription-drug-user-fee-act-waivers-reductions-and-refunds-for-drug-and-biological-products-guidance-for-industry/1a0bec17-eee8-4dda-9b43-4ca488355d7f)
- [S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers](https://www.keypedia.com/guidances/guidance-document/s9-nonclinical-evaluation-for-anticancer-pharmaceuticals-questions-and-answers/5b838cf4-2c2e-4c10-8a24-439ce4ce61f1)
- [E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers](https://www.keypedia.com/guidances/guidance-document/e2cr2-periodic-benefit-risk-evaluation-report-questions-and-answers/9735c0c5-468e-4e9b-a4c9-a7bad1eb9d94)